Detalhe da pesquisa
1.
A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma.
Cancer
; 126(20): 4532-4544, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32767682
2.
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.
J Clin Oncol
; 40(12): 1312-1322, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35089812
3.
A phase II trial of durvalumab and tremelimumab in metastatic, non-urothelial carcinoma of the urinary tract.
Cancer Med
; 10(3): 1074-1083, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33382520
4.
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer.
J Clin Oncol
; 36(19): 1949-1956, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29742009
5.
Cancer Immunotherapy: An Evidence-Based Overview and Implications for Practice.
Clin J Oncol Nurs
; 21(2 Suppl): 13-21, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28315552
6.
Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma.
Bladder Cancer
; 2(1): 111-117, 2016 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27376132